Cresco Labs Stock Performance
| CRLBF Stock | USD 1.18 0.02 1.67% |
The firm shows a Beta (market volatility) of -0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cresco Labs are expected to decrease at a much lower rate. During the bear market, Cresco Labs is likely to outperform the market. At this point, Cresco Labs has a negative expected return of -0.35%. Please make sure to confirm Cresco Labs' potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if Cresco Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cresco Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 140.8 M | |
| Total Cashflows From Investing Activities | -163.9 M |
Cresco |
Cresco Labs Relative Risk vs. Return Landscape
If you would invest 165.00 in Cresco Labs on September 4, 2024 and sell it today you would lose (47.00) from holding Cresco Labs or give up 28.48% of portfolio value over 90 days. Cresco Labs is currently producing negative expected returns and takes up 5.9841% volatility of returns over 90 trading days. Put another way, 53% of traded otc stocks are less volatile than Cresco, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cresco Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cresco Labs' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Cresco Labs, and traders can use it to determine the average amount a Cresco Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0585
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CRLBF |
Estimated Market Risk
| 5.98 actual daily | 53 53% of assets are less volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cresco Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cresco Labs by adding Cresco Labs to a well-diversified portfolio.
Cresco Labs Fundamentals Growth
Cresco OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Cresco Labs, and Cresco Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cresco OTC Stock performance.
| Return On Equity | -0.0635 | |||
| Return On Asset | 0.0399 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 1.29 B | |||
| Shares Outstanding | 280.99 M | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 0.83 X | |||
| Revenue | 821.68 M | |||
| EBITDA | (159.63 M) | |||
| Cash And Equivalents | 130.04 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 465.08 M | |||
| Debt To Equity | 0.88 % | |||
| Book Value Per Share | 2.62 X | |||
| Cash Flow From Operations | 14.49 M | |||
| Earnings Per Share | (1.15) X | |||
| Total Asset | 1.78 B | |||
About Cresco Labs Performance
By analyzing Cresco Labs' fundamental ratios, stakeholders can gain valuable insights into Cresco Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cresco Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cresco Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. The company was founded in 2013 and is headquartered in Chicago, Illinois. Cresco Labs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3300 people.Things to note about Cresco Labs performance evaluation
Checking the ongoing alerts about Cresco Labs for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Cresco Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cresco Labs generated a negative expected return over the last 90 days | |
| Cresco Labs has high historical volatility and very poor performance | |
| Cresco Labs may become a speculative penny stock | |
| Cresco Labs has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 821.68 M. Net Loss for the year was (319.6 M) with profit before overhead, payroll, taxes, and interest of 429.79 M. | |
| About 23.0% of the company shares are held by company insiders |
- Analyzing Cresco Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cresco Labs' stock is overvalued or undervalued compared to its peers.
- Examining Cresco Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cresco Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cresco Labs' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Cresco Labs' otc stock. These opinions can provide insight into Cresco Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cresco OTC Stock analysis
When running Cresco Labs' price analysis, check to measure Cresco Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cresco Labs is operating at the current time. Most of Cresco Labs' value examination focuses on studying past and present price action to predict the probability of Cresco Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cresco Labs' price. Additionally, you may evaluate how the addition of Cresco Labs to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |